Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Johnson & Johnson
Woman and Man Max 99 years
Johnson & Johnson (The Netherlands)
Update Il y a 4 ans
Risk adapted treatment of Acute Myelocytic Leukaemia (AML)
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Johnson & Johnson Pharmaceutical Research and Development
Update Il y a 4 ans
A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer
The primary objective of this study is to evaluate whether the overall survival for the DOXIL/CAELYX and docetaxel treatment group is superior to that of the group treated with docetaxel monotherapy
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research and Development, L.L.C
Update Il y a 4 ans
A comparison of the effectiveness and safety of topiramate and phenytoin in patients with new onset epilepsy requiring rapid initiation of antiepileptic drug treatment
The purpose of this study is to compare the effectiveness and safety of two treatment regimens, topiramate as compared to phenytoin, in preventing seizures in patients with new-onset epilepsy who requ...
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Johnson & Johnson Pharmaceutical Research & Development, L.L.C
Update Il y a 4 ans
A Safety Study of Mebendazole in Children 2 to 10 Years of Age
The primary objective of this study was to assess the safety and tolerability of a mebendazole 500-mg chewable tablet formulation in a pediatric population (children 2 to 10 years of age, inclusive).
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Johnson & Johnson Pharamceutical Resarch & Development, L.L.C
Update Il y a 4 ans
A One-Year, Randomized, Open-Label, Parallel-Arm, Phase III Long-Term Safety Trial, with Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR* and Oxycodone CR in Subjects with Chronic Pain
The primary objective of the trial is the evaluation of the safety profile of CG5503 PR base at doses ranging between 100 mg and 250 mg BID over long term exposure of up to one year.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Janssen Cliag Ltd. C/O Johnson & Johnson PRD
Update Il y a 4 ans
A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS
To determine whether R317573, after multiple dosing over one week, reduces the intensity of an anxiogenic reaction induced by the intravenous (i.v.) administration of cholecystokinin-tetrapeptide (CCK...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Johnson & Johnson Wound Management (UK)
Update Il y a 4 ans
PROtease modulating dressings in the treatment of chronic wounds: finding bioMARKers to predict healing response
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Johnson & Johnson
Update Il y a 4 ans
J&J CR015769 : Essai de phase 3 randomisé comparant l'efficacité de la trabectedin à une chimiothérapie à base de doxorubicine, en traitement de 1ère ligne, chez des patients ayant un sarcome des tissus mous avec translocation chromosomique, [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized, multicenter, phase III trial of trabectedin (Yondelis) versus doxorubicin-based chemotherapy as first-line therapy in patients with translocation-related sarcomas (TRS)
Country
France
organs
Sarcomes
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
DePuy Synthes (Johnson & Johnson Medial Products GmbH)
Update Il y a 4 ans
Comparison of two different surgical approaches to decompress lumbar spinal nerves in patients with narrow lumbar spinal canal and instability
Background and study aims Spinal fusion surgery (spondylodesis) is a type of surgical procedure which joins two or more vertebrae (small bones that make up the spine) together. It is more often used t...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man
Between 18 years
and 99 years
Johnson & Johnson
Update Il y a 4 ans
JOHNSON&JOHNSON CR016057 : Essai de phase 2 randomisé, en double aveugle, comparant l'efficacité et la tolérance du JNJ-42160443 à un placebo dans le traitement de la douleur, chez des patients ayant un cancer. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of JNJ-42160443 as adjunctive therapy in subjects with cancer-related pain, followe...
Country
France
organs
Tout Cancer
Specialty
Autres (cryothérapie, radiofréquence, homéopathie,...)
Essai clos aux inclusions
More information
Previous
1
2
3
4
Next